Treatment of severe malaria with injectable quinine
Phase 2
Recruiting
- Conditions
- malaria
- Registration Number
- JPRN-jRCTs071180063
- Lead Sponsor
- Maruyama Haruhiko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
1) Severe malaria patient, or malaria patient who cannot take oral antimalarial medicines for absolute contraindication or other reasons
2) Patient who gives written informed consent on his/her own free will to participate the above described study, after having fully understood the explanations on it
3) Patient whose legal representative gives written informed consent on his/her own free will to let the patient participate the above described study, after having fully understood the explanations on it
Exclusion Criteria
1) Patient who is allergic to quinine
2) Patient who refuses quinine injection
3) Patient principal investigator judged inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method